Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Thermo Fisher Scientific India Private Limited is a leading provider of scientific instrumentation and laboratory services that operates in the life sciences and analytical markets. It offers a diverse range of products including analytical instruments, laboratory reagents, and consumables, supporting research and diagnostics in areas such as pharmaceuticals, biotechnology, and environmental science.
Thermo Fisher Scientific India Private Limited, is an unlisted private company incorporated on 31 May, 2000. It is classified as a private limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 16.10 cr and the total paid-up capital is INR 14.53 cr.
Read more
** All rupee values in INR crores. Based on March 2025 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Krishna Murthy Perumal | 09163497 | 5 years |
| Person Incharge | Vivek Rathi | 02463012 | 14 years |
| Additional Director | Dibyendu Chakrabarti Thakur | 09343376 | 1 years |
| Additional Director | Keyur Ilesh Pandya | 11522142 | 1 years |
| Managing Director | Srinath Venkatesh | 07955613 | 3 years |
| Director | Jitesh Kakaria | 10457585 | 3 years |
| Additional Director | Nilesh Avinash Limaye | 07855620 | 0 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | 1,216.5 | 1,588.9 | 1,715.0 | 2,083.9 | 2,528.9 |
| Operating profit | 97.3 | 152.1 | 166.6 | 185.7 | 140.0 |
| Net profit | 67.3 | 100.7 | 112.4 | 114.0 | 112.7 |
| Gross margin | 39.7 | 37.7 | 40.1 | 36.4 | 33.6 |
| Operating margin | 8.0 | 9.6 | 9.7 | 8.9 | 5.5 |
| Net margin | 5.4 | 6.2 | 6.4 | 5.4 | 4.4 |
| Networth | 560.2 | 660.7 | 768.1 | 899.6 | 831.7 |
| Borrowings | - | - | - | - | - |
| Assets | 1,096.7 | 1,286.3 | 1,458.8 | 1,660.1 | 1,716.3 |
| Debt to equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current ratio | 2.0 | 1.7 | 1.9 | 2.1 | 1.9 |
| ROE | 12.0 | 15.2 | 14.6 | 12.7 | 13.6 |
| Days payable | 159.0 | 118.0 | 131.0 | 127.0 | 125.0 |
| WC days | 146.0 | 90.0 | 114.0 | 129.0 | 95.0 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 14.5 | 14.5 | 14.5 | 14.5 | 14.5 |
| Reserves | 545.7 | 646.2 | 753.5 | 885.1 | 817.2 |
| Borrowings + | - | - | - | - | - |
| Long term borrowings | - | - | - | - | - |
| Short term borrowings | - | - | - | - | - |
| Trade payables + | 320.5 | 320.9 | 369.7 | 462.1 | 573.7 |
| Days payable | 159.0 | 118.0 | 131.0 | 127.0 | 125.0 |
| Other liabilities + | 216.0 | 304.7 | 321.1 | 298.4 | 310.9 |
| Other non-current liabilities | 45.8 | 91.5 | 93.9 | 103.2 | 108.6 |
| Other current liabilities | 170.3 | 213.2 | 227.2 | 195.2 | 202.4 |
| Total liabilities | 1,096.7 | 1,286.3 | 1,458.8 | 1,660.1 | 1,716.3 |
| Fixed Assets + | 90.4 | 144.6 | 164.4 | 146.7 | 158.2 |
| Tangible assets | 17.0 | 24.0 | 38.0 | 101.7 | 114.2 |
| CWIP | 30.5 | 76.9 | 80.5 | 0.2 | 1.4 |
| Intangible assets | 42.8 | 43.7 | 45.9 | 44.8 | 42.5 |
| LT loans and advances | 7.6 | 186.9 | 122.5 | 50.0 | - |
| Other non-current assets | 21.3 | 29.9 | 37.6 | 71.3 | 121.9 |
| Current assets + | 977.4 | 924.9 | 1,134.3 | 1,392.2 | 1,436.3 |
| Inventories | 173.6 | 208.3 | 249.5 | 285.6 | 384.5 |
| Trade receivables | 258.5 | 242.8 | 316.7 | 396.0 | 514.8 |
| Cash and cash equivalents | 441.3 | 304.9 | 325.7 | 498.8 | 175.4 |
| ST loans and advances | 8.7 | 55.4 | 57.5 | 72.5 | 50.0 |
| Other current assets | 95.3 | 113.6 | 184.9 | 139.3 | 311.6 |
| Total assets | 1,096.7 | 1,286.3 | 1,458.8 | 1,660.1 | 1,716.3 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales + | 1,216.5 | 1,588.9 | 1,715.0 | 2,083.9 | 2,528.9 |
| Sales growth % | 18.79 | 30.62 | 7.94 | 21.51 | 21.35 |
| Expenses + | 1,145.3 | 1,468.5 | 1,589.2 | 1,945.8 | 2,438.6 |
| Cost of goods | 733.5 | 990.5 | 1,026.4 | 1,325.5 | 1,680.2 |
| Employee cost | 260.8 | 285.9 | 302.5 | 346.6 | 391.6 |
| Other costs | 124.9 | 160.4 | 219.5 | 226.1 | 317.0 |
| Operating profit + | 97.3 | 152.1 | 166.6 | 185.7 | 140.0 |
| Operating margin % | 8.0 | 9.6 | 9.7 | 8.9 | 5.5 |
| Other income | 27.3 | 22.7 | 31.7 | 32.8 | 25.5 |
| Interest | 3.4 | 4.0 | 6.6 | 6.7 | 5.1 |
| Depreciation | 22.8 | 27.7 | 34.1 | 40.9 | 44.7 |
| Exceptional items | - | - | - | - | - |
| Profit before tax | 98.4 | 143.1 | 157.6 | 170.9 | 115.7 |
| Tax | 31.1 | 42.5 | 45.1 | 56.9 | 3.1 |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | 67.3 | 100.7 | 112.4 | 114.0 | 112.7 |
| Net margin % | 5.4 | 6.2 | 6.4 | 5.4 | 4.4 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Debt/Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Debt/Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Assets/Equity | 2.0 | 1.9 | 1.9 | 1.9 | 2.1 |
| Liquidity + | |||||
| Current Ratio | 2.0 | 1.7 | 1.9 | 2.1 | 1.9 |
| Quick Ratio | 1.6 | 1.3 | 1.5 | 1.7 | 1.4 |
| Interest Coverage | 29.0 | 38.0 | 25.1 | 27.7 | 27.6 |
| Performance | |||||
| Gross Margin | 39.7 | 37.7 | 40.1 | 36.4 | 33.6 |
| Operating Margin | 8.0 | 9.6 | 9.7 | 8.9 | 5.5 |
| Net Margin | 5.4 | 6.2 | 6.4 | 5.4 | 4.4 |
| Return + | |||||
| Return on Equity | 12.0 | 15.2 | 14.6 | 12.7 | 13.6 |
| Pre-tax ROCE | 12.9 | 23.2 | 18.9 | 16.4 | 11.7 |
| Return on Assets | 6.1 | 7.8 | 7.7 | 6.9 | 6.6 |
| Pre-tax ROIC | 13.3 | 18.8 | 17.2 | 16.1 | 11.5 |
| Efficiency + | |||||
| Days Payable | 159.0 | 118.0 | 131.0 | 127.0 | 125.0 |
| Days Inventory | 86.0 | 77.0 | 89.0 | 79.0 | 84.0 |
| Days Receivable | 78.0 | 56.0 | 67.0 | 69.0 | 74.0 |
| Fixed Asset Turnover | 13.5 | 11.0 | 10.4 | 14.2 | 16.0 |
| Total Asset Turnover | 1.1 | 1.2 | 1.2 | 1.3 | 1.5 |
| Working Capital | |||||
| Cash Conversion Cycle | 5.0 | 15.0 | 25.0 | 21.0 | 33.0 |
| Working Capital Days | 146.0 | 90.0 | 114.0 | 129.0 | 95.0 |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| AMERICAN EXPRESS INTERNATIONAL (INDIA) P RIVATE LIMITED |
Dissolved
|
101.3 Cr | 1 | Delhi |
| TKA INDIA PRIVATE LIMITED |
Amalgamated
|
12.6 L | 1 | Maharashtra |
| KENDRO LABORATORY PRODUCTS INDIA PRIVATE LIMITED |
Amalgamated
|
50.0 L | 1 | Maharashtra |
| ROCHE INDIA HEALTHCARE INSTITUTE |
Active
|
0.0 | 1 | Maharashtra |
| ROCHE PRODUCTS (INDIA) PRIVATE LIMITED |
Active
|
1.4 Cr | 1 | Maharashtra |
Read more
The incorporation date of THERMO FISHER SCIENTIFIC INDIA PRIVATE LIMITED is 31 May, 2000
The authorized share capital of THERMO FISHER SCIENTIFIC INDIA PRIVATE LIMITED is INR ₹ 16.1 Cr.
The paid-up capital of THERMO FISHER SCIENTIFIC INDIA PRIVATE LIMITED is INR ₹ 14.5 Cr.
The registered address of THERMO FISHER SCIENTIFIC INDIA PRIVATE LIMITED is 403-404, B-Wing, Delphi, Hiranandani Business Park, Powai Mumbai Maharashtra - 400076
The CIN number of THERMO FISHER SCIENTIFIC INDIA PRIVATE LIMITED is U73100MH2000PTC126872.